BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34628481)

  • 21. Anaplastic large cell lymphoma, ALK-negative.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
    Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype,
    Qiu L; Medeiros LJ; Tang G; Khanlari M; Li S; Konoplev S; Wang SA; Yin CC; Khoury JD; Wang W; Miranda RN; Iyer S; You MJ; Xu J
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.
    Wang YF; Yang YL; Gao ZF; Zhou CJ; Gregg X; Shi YF; Wang J; Yang XF; Ke XY
    J Hematol Oncol; 2012 Jul; 5():38. PubMed ID: 22769020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
    Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
    Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary gastrointestinal anaplastic large cell lymphoma.
    Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
    Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma.
    Wang X; Wu J; Zhang M
    Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK-positive anaplastic large cell lymphoma with a monomorphic small-cell pattern masquerading as inflammatory gastric lesions.
    Lee JS; Choi SJ; Kim L; Park IS; Han JY; Kim JM; Chu YC
    Malays J Pathol; 2019 Aug; 41(2):213-222. PubMed ID: 31427559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
    Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation of recurrent ALK-positive anaplastic large-cell lymphoma from common pattern to composite pattern (lymphohistiocytic and small-cell pattern) with a change in CD30 expression.
    Ji L; Liu C; Zhao S
    Int J Hematol; 2023 Jul; 118(1):131-134. PubMed ID: 36735219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
    Suzuki R; Kagami Y; Takeuchi K; Kami M; Okamoto M; Ichinohasama R; Mori N; Kojima M; Yoshino T; Yamabe H; Shiota M; Mori S; Ogura M; Hamajima N; Seto M; Suchi T; Morishima Y; Nakamura S
    Blood; 2000 Nov; 96(9):2993-3000. PubMed ID: 11049976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic abnormality and protein expression of C-MYC and PD-L1 in ALK-negative anaplastic large cell lymphoma].
    Wang C; Chen X; Chen XY; You ZJ
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):598-603. PubMed ID: 34078046
    [No Abstract]   [Full Text] [Related]  

  • 34. Flow cytometric immunophenotyping of anaplastic large cell lymphoma.
    Muzzafar T; Wei EX; Lin P; Medeiros LJ; Jorgensen JL
    Arch Pathol Lab Med; 2009 Jan; 133(1):49-56. PubMed ID: 19123736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical characteristics and prognostic factors of 40 cases of primary systemic anaplastic large cell lymphoma].
    Chen YK; Yu WJ; Liu H; Wei JY; Qian WB; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):222-227. PubMed ID: 32311892
    [No Abstract]   [Full Text] [Related]  

  • 36. ALK-negative anaplastic large cell lymphoma with
    Sibon D; Bisig B; Bonnet C; Poullot E; Bachy E; Cavalieri D; Fataccioli V; Bregnard C; Drieux F; Bruneau J; Lemonnier F; Dupuy A; Bossard C; Parrens M; Bouabdallah K; Ketterer N; Berthod G; Cairoli A; Damaj G; Tournilhac O; Jais JP; Gaulard P; De Leval L
    Haematologica; 2023 Jun; 108(6):1590-1603. PubMed ID: 36453105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.
    Sherman CG; Zielenska M; Lorenzana AN; Pulford KA; Mason DY; Hutchison RE; Thorner PS
    Pediatr Dev Pathol; 2001; 4(2):129-37. PubMed ID: 11178628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biology and management of systemic anaplastic large cell lymphoma.
    Hapgood G; Savage KJ
    Blood; 2015 Jul; 126(1):17-25. PubMed ID: 25869285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
    Shin HJ; Thorson P; Gu J; Katz RL
    Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant.
    Jagasia M; Morgan D; Goodman S; Hamilton K; Kinney M; Shyr Y; Stein R; Zic J; Greer J
    Leuk Lymphoma; 2004 Nov; 45(11):2261-7. PubMed ID: 15512815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.